SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Lifestyles Remedies becomes subsidiary of Bafna Pharmaceuticals

03 Aug 2011 Evaluate

Bafna Lifestyles Remedies has become a subsidiary company of Bafna Pharmaceuticals in accordance with the provisions of the Companies Act, 1956. Recently, Bafna Pharmaceuticals had concluded the deal with NR Jet, an affiliate of Johnson & Johnson and had acquired the well established pharmaceutical brand “RARICAP”. The brand “RARICAP” has a legacy of over 40 years in the market. It is prescribed for iron deficiency anemia in women - especially during pregnancy.

Bafna Pharmaceuticals started its production with tablets facility and subsequently added capsule and oral syrup facilities respectively. BAFNA always focused on institutional and generic supply to keep its production line busy. It also concentrated on registering its products in the international market.

Bafna Pharma Share Price

137.90 -7.10 (-4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×